News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,400 Results
Type
Article (152)
Company Profile (1)
Press Release (2247)
Section
Business (643)
Deals (102)
Drug Delivery (1)
Drug Development (387)
FDA (92)
Job Trends (62)
News (1208)
Policy (105)
Tag
Academia (12)
Alliances (139)
Alzheimer's disease (3)
Approvals (94)
Artificial intelligence (3)
Autoimmune disease (4)
Best Places to Work (56)
Bladder cancer (6)
Brain cancer (2)
Cancer (18)
Cardiovascular disease (1)
CDC (1)
Cell therapy (3)
Clinical research (352)
Collaboration (2)
Company closure (1)
Compensation (29)
COVID-19 (3)
C-suite (8)
Cystic fibrosis (3)
Data (31)
Diabetes (2)
Diagnostics (6)
Drug discovery (1)
Earnings (289)
Events (374)
Executive appointments (4)
FDA (106)
Funding (10)
Gene editing (1)
Generative AI (1)
Gene therapy (4)
GLP-1 (4)
Government (14)
Guidances (1)
Healthcare (94)
IgA nephropathy (4)
Immunology and inflammation (1)
Indications (1)
Infectious disease (3)
Intellectual property (1)
IPO (49)
Job creations (9)
Layoffs (4)
Legal (5)
Lung cancer (1)
Lymphoma (3)
Manufacturing (4)
Medical device (39)
Medtech (39)
Mergers & acquisitions (60)
Metabolic disorders (5)
Multiple sclerosis (1)
Neuroscience (5)
NextGen: Class of 2026 (48)
Non-profit (6)
Obesity (2)
Partnered (1)
Patents (1)
Patient recruitment (3)
People (217)
Phase 1 (98)
Phase 2 (118)
Phase 3 (151)
Pipeline (27)
Postmarket research (25)
Preclinical (29)
Press Release (1)
Prostate cancer (1)
Radiopharmaceuticals (2)
Rare diseases (8)
Real estate (7)
Regulatory (104)
Research institute (15)
Series A (2)
Series B (3)
Sickle cell disease (1)
Spinal muscular atrophy (1)
Startups (9)
Vaccines (3)
Weight loss (3)
Date
Last 7 days (2)
Last 30 days (8)
Last 365 days (177)
2026 (12)
2025 (183)
2024 (197)
2023 (206)
2022 (215)
2021 (235)
2020 (204)
2019 (165)
2018 (139)
2017 (121)
2016 (97)
2015 (122)
2014 (84)
2013 (57)
2012 (50)
2011 (46)
2010 (61)
Location
Africa (1)
Asia (147)
Australia (10)
California (20)
Canada (45)
China (7)
Connecticut (1)
Delaware (1)
Europe (312)
Idaho (3)
Illinois (1)
Japan (1)
Kentucky (1)
Maryland (1)
Massachusetts (196)
Nevada (1)
New Jersey (8)
New York (18)
North Carolina (13)
Northern California (9)
Ohio (1)
Pennsylvania (3)
South America (2)
Southern California (8)
Texas (3)
United States (263)
2,400 Results for "vor bio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vor Bio Announces $150 Million Private Placement
December 16, 2025
·
4 min read
Press Releases
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Vor Bio to Participate in Upcoming Investor Conferences - November 7, 2025
November 10, 2025
·
1 min read
Press Releases
Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock
November 10, 2025
·
3 min read
Press Releases
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 11, 2025
·
4 min read
Press Releases
Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 14, 2025
·
10 min read
Press Releases
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer
November 4, 2025
·
4 min read
Press Releases
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
December 24, 2025
·
3 min read
Press Releases
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 31, 2025
November 2, 2025
·
1 min read
Press Releases
Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
September 15, 2025
·
1 min read
1 of 240
Next
